Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages

Biochemical and Biophysical Research Communications

Volumn 370, Issue 2, 2008, Pages 348-352

  Olofsson, Katarina E ^a   Andersson, Linda ^a   Nilsson, Jan ^a   Björkbacka, Harry ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; Chemotaxis; Inflammation; Lysophosphatidylcholine; Monocyte macrophages

Indexed keywords

CYTOKINE; LYSOPHOSPHATIDYLCHOLINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL2; CHEMOTAXIS; CYTOKINES; INFLAMMATION; LYSOPHOSPHATIDYLCHOLINES; MACROPHAGES; MICE; MONOCYTES; RNA, MESSENGER;

EID: 42249091172     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.087     Document Type: Article

References (22)

1. Navab M., Ananthramaiah G.M., Reddy S.T., Van Lenten B.J., Ansell B.J., Fonarow G.C., Vahabzadeh K., Hama S., Hough G., Kamranpour N., Berliner J.A., Lusis A.J., and Fogelman A.M. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J. Lipid Res. 45 (2004) 993-1007
2. Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr. Opin. Lipidol. 14 (2003) 421-430
3. Ninio E. Phospholipid mediators in the vessel wall: involvement in atherosclerosis. Curr. Opin. Clin. Nutr. Metab. Care 8 (2005) 123-131
4. Esterbauer H., Gebicki J., Puhl H., and Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13 (1992) 341-390
5. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., and Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84 (1989) 1086-1095
6. Marathe G.K., Silva A.R., de Castro Faria Neto H.C., Tjoelker L.W., Prescott S.M., Zimmerman G.A., and McIntyre T.M. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. J. Lipid Res. 42 (2001) 1430-1437
7. Chen L., Liang B., Froese D.E., Liu S., Wong J.T., Tran K., Hatch G.M., Mymin D., Kroeger E.A., Man R.Y., and Choy P.C. Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation. J. Lipid Res. 38 (1997) 546-553
8. Zalewski A., Nelson J.J., Hegg L., and Macphee C. Lp-PLA2: a new kid on the block. Clin. Chem. 52 (2006) 1645-1650
9. Jenny N.S. Lipoprotein-associated phospholipase A2: novel biomarker and causal mediator of atherosclerosis?. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2417-2418
10. Zalewski A., and Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 923-931
11. Kougias P., Chai H., Lin P.H., Lumsden A.B., Yao Q., and Chen C. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med. Sci. Monit. 12 (2006) RA5-RA16
12. Kume N., Cybulsky M.I., and Gimbrone Jr. M.A. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90 (1992) 1138-1144
13. Takahara N., Kashiwagi A., Maegawa H., and Shigeta Y. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism 45 (1996) 559-564
14. Liu-Wu Y., Hurt-Camejo E., and Wiklund O. Lysophosphatidylcholine induces the production of IL-1beta by human monocytes. Atherosclerosis 137 (1998) 351-357
15. Quinn M.T., Parthasarathy S., and Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA 85 (1988) 2805-2809
16. Radu C.G., Yang L.V., Riedinger M., Au M., and Witte O.N. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proc. Natl. Acad. Sci. USA 101 (2004) 245-250
17. Lauber K., Bohn E., Krober S.M., Xiao Y.J., Blumenthal S.G., Lindemann R.K., Marini P., Wiedig C., Zobywalski A., Baksh S., Xu Y., Autenrieth I.B., Schulze-Osthoff K., Belka C., Stuhler G., and Wesselborg S. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113 (2003) 717-730
18. Meyer zu Heringdorf D., and Jakobs K.H. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim. Biophys. Acta. 1768 (2007) 923-940
19. Yang L.V., Radu C.G., Wang L., Riedinger M., and Witte O.N. Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood 105 (2005) 1127-1134
20. Lavi S., McConnell J.P., Rihal C.S., Prasad A., Mathew V., Lerman L.O., and Lerman A. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 115 (2007) 2715-2721
21. Subbaiah P.V., Chen C.H., Bagdade J.D., and Albers J.J. Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction. J. Biol. Chem. 260 (1985) 5308-5314
22. Kim Y.L., Im Y.J., Ha N.C., and Im D.S. Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding. Prostaglandins Other Lipid Mediat. 83 (2007) 130-138